News Releases

Find an Article

Hospitals:








 

Main Line Health Twitter Feed

Go to page:

<  1  2  3  4  5   >
  1. Lankenau Institute for Medical Research President to be a Panelist in Cancer Moonshot Summit
    Wednesday, June 15, 2016
    George Prendergast, PhD, will participate as a panelist in the upcoming Cancer Moonshot Summit to be held June 29 at Fox Chase Cancer Center in Philadelphia.
  2. Main Line HealthCare Physician Network and Marks Colorectal Surgical Associates Announce Opening of the Colorectal Center at Lankenau Medical Center
    Wednesday, June 15, 2016
    Main Line HealthCare (MLHC) and the physicians of Marks Colorectal Surgical Associates announce the opening of the Colorectal Center at Lankenau Medical Center.
  3. Sean Wright, MD, FACS, Appointed to The Riddle HealthCare Foundation Board of Directors
    Wednesday, May 11, 2016
    The Riddle HealthCare Foundation, part of Main Line Health (MLH), has elected Sean Wright, MD, FACS, to its Board of Directors.
  4. Lankenau Institute for Medical Research President and CEO Invited to Speak at Three Oncology and Biotechnology Conferences this Spring
    Tuesday, April 19, 2016
    George Prendergast, PhD, CEO and President of the Lankenau Institute for Medical Research (LIMR), is scheduled to speak at three prestigious conferences this spring.
  5. Lankenau Medical Center Colorectal Surgeon Performs 2,000th Laparoscopic Colon Resection
    Tuesday, March 29, 2016
    John Marks, Section Chief of Colorectal Surgery at Main Line Health, and Medical Director of the Colorectal Cancer Program at Lankenau Medical Center, recently performed his 2,000th colon resection.
  6. Innovative Approach to Ovarian Cancer Treatment Unveiled by Biomedical Scientists at the Lankenau Institute for Medical Research
    Tuesday, March 8, 2016
    A new precision medicine approach to treat the most aggressive forms of ovarian cancer was recently announced by a consortium of researchers led by Janet Sawicki, PhD.
  7. Cancer Immunotherapy: Lankenau Institute for Medical Research and Lankenau Medical Center Experts Review Cutting-Edge Recent Advances
    Tuesday, February 23, 2016
    LIMR scientists published a teaching article to illuminate the basic research findings of the human immune system function and its application to treating cancer more effectively.
  8. Lankenau Institute for Medical Research Professor Elected to Chair Prestigious International Conference
    Tuesday, February 23, 2016
    Susan Gilmour, PhD has been elected by her scientific peers to chair the distinguished Gordon Research Conference on Polyamines to be held in New Hampshire in 2017.
  9. Lankenau Institute for Medical Research President Participates in Cancer Precision Medicine Conference
    Thursday, January 28, 2016
    George Prendergast, President and CEO of LIMR, was a panelist at the Cancer Precision Medicine conference sponsored by the American Association for Cancer Research and the Philadelphia Media Network.
  10. LIMR Researcher to Release Two-Volume Text on Vaccines
    Thursday, January 28, 2016
    Sunil Thomas, PhD, Research Assistant Professor at LIMR, will shortly release a new two-volume textbook that provides protocols for scientists and researchers working on vaccine design and development
  11. Two Conferences Invite LIMR Researcher to Discuss Her Groundbreaking Immunology Studies
    Monday, January 18, 2016
    Laura Mandik-Nayak, PhD, Associate Professor at the Lankenau Institute for Medical Research, was invited to speak at two conferences in September on the topic of her research.
  12. Lankenau Institute for Medical Research and Lankenau Medical Center Researchers Uncover New Potential Therapeutic Approach for Ulcerative Colitis
    Friday, January 15, 2016
    A new therapeutic target for ulcerative colitis (UC) was proposed by researchers at the Lankenau Institute for Medical Research (LIMR) and Lankenau Medical Center (LMC).
  13. Main Line HealthCare Welcomes Xiaomang Stickles, MD, to Main Line HealthCare Gynecologic Oncology
    Monday, January 11, 2016
  14. New Potential Approach to Treat Pancreatic Cancer is Unveiled by LIMR Researcher and Colleagues
    Wednesday, December 2, 2015
    Blocking the actions of a specific protein has been shown to stop the malignant qualities of pancreatic ductal adenocarcinoma (PDA), according to new studies from an investigative team at LIMR.
  15. Lankenau Institute for Medical Research Obtains Three New Grants to Further Research Cancer and Lupus Treatments
    Tuesday, November 24, 2015
    The Lankenau Institute for Medical Research (LIMR), part of Main Line Health, has been awarded three grants to support ongoing clinical research.

Go to page:

<  1  2  3  4  5   >

Connect with MLH

New Appointments
1.866.CALL.MLH

 Well Ahead Newsletter


STAY CONNECTED

Copyright 2016 Main Line Health

Printed from: www.mainlinehealth.org/wtn/Page.asp

The information provided in this Web site is for informational purposes only. It is not a substitute for medical advice. All medical information presented should be discussed with your healthcare professional. See additional Terms of Use at www.mainlinehealth.org/terms. For more information, call 1.866.CALL.MLH.